PTGX
Protagonist Therapeutics, Inc- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $151.42
- As of
Share the PTGX intelligence card
See PTGX live in the terminal
Track PTGX's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live PTGX terminal, freeActive signals for PTGX
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 7.8%, EPS $2.29 vs $2.1238 estimate
- mediumNEW_POSITION
Bridgewater Associates, LP new position in PTGX
- mediumEARNINGS_BEAT
Q2-2025: Beat consensus by 6.8% - EPS $-0.55 vs $-0.59 estimate
- mediumEARNINGS_BEAT
Beat consensus by 6.8% - EPS $-0.55 vs $-0.59 estimate
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 109.2% - EPS $0.05 vs $-0.5435 estimate
Top institutional holders of PTGX (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| SOROS FUND MANAGEMENT LLC | $8.7M | 0.10% | , |
| MILLENNIUM MANAGEMENT LLC | $8.5M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLC | $1.5M | 0.00% | -86.4% |
| RENAISSANCE TECHNOLOGIES LLC | $713K | 0.00% | , |
| CITADEL ADVISORS LLC | $559K | 0.00% | +3.2% |
| Bridgewater Associates, LP | $556K | 0.00% | , |
| CITADEL ADVISORS LLC | $412K | 0.00% | , |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, PTGX
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
Related tickers
Catch the next move on names like this
New 13F filings, insider trades, and cross asset signals like the ones above, in your inbox each morning or live on Telegram. Free, no account.
One email a day. Unsubscribe anytime. We never sell your data.
See more PTGX signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to PTGXand get the insider, 13F, options, and confluence read in one view.